Drugmaker AbbVie will pay $24 million to settle fraud lawsuit over Humira marketing

Pharmaceutical giant AbbVie, based in Chicago's northern suburbs, has agreed to a $24 million settlement that will require it to change its marketing practices for its immunology drug Humira.